LOGIN  |  REGISTER

Masimo (NASDAQ: MASI) Stock Quote

Last Trade: US$137.92 -4.83 -3.38
Volume: 505,189
5-Day Change: -1.70%
YTD Change: 17.67%
Market Cap: US$7.300B

Latest News From Masimo

Politan’s Efforts to Take Control of Masimo Are Not in Stockholders’ Best Interests IRVINE, Calif. / Apr 01, 2024 / Business Wire / Masimo (NASDAQ: MASI) today confirmed that Politan Capital Management LP (“Politan”) has provided notice of its intent to nominate two candidates to stand for election to the Masimo Board of Directors at the company’s 2024 Annual Meeting. While Masimo respects and values the input and ideas of... Read More
IRVINE, Calif. / Mar 22, 2024 / Business Wire / Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that its Board of Directors has authorized management to evaluate a proposed separation of its consumer business. The Board and management will evaluate the proposed structure of the separation. Masimo expects that the separation will include its consumer audio and... Read More
HealthStocksHub
IRVINE, Calif. / Mar 19, 2024 / Business Wire / Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, is thrilled to announce its recognition as one of Fast Company’s Most Innovative Companies in North America for 2024. This prestigious accolade is especially meaningful given... Read More
IRVINE, Calif. / Mar 04, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 2024 at 3:25 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo... Read More
Fourth Quarter 2023 Highlights: Consolidated revenue was $548.9 million; Healthcare revenue was $339.9 million; Non-healthcare revenue was $209.0 million; GAAP net income per diluted share of $0.63; and Non-GAAP net income per diluted share (updated definition) of $1.25. Full-Year 2023 Highlights: Consolidated revenue was $2,048.1 million; Healthcare revenue was $1,275.5 million; Non-healthcare revenue was $772.6 million.... Read More
IRVINE, Calif. & DENVER / Feb 20, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and UCHealth , a nationally recognized network of hospitals, clinics, and providers based in Colorado, announced today that they are entering into a strategic collaboration to improve the standard of patient care using the latest in virtual care and telehealth capabilities.... Read More
HealthStocksHub
Masimo MightySat ® Medical Provides Clinically Proven Masimo SET ® Pulse Oximetry to Consumers for Medical Use Without a Prescription IRVINE, Calif. / Feb 13, 2024 / Business Wire / Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse... Read More
HealthStocksHub
IRVINE, Calif. / Feb 08, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical Monitoring and Computing in which Dr. Vikrant Sharma, along with Dr. Steven J. Barker, Dr. William C. Wilson, and colleagues at Masimo performed a... Read More
HealthStocksHub
IRVINE, Calif. / Jan 17, 2024 / Business Wire / Masimo ( NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, welcomes the Federal Circuit’s ruling to lift the temporary stay on the import ban of certain Apple Watch models. This decision reinstates the U.S. International Trade Commission’s import... Read More
Bob Chapek Joins Masimo’s Board of Directors IRVINE, Calif. / Jan 16, 2024 / Business Wire / Masimo (NASDAQ: MASI) announced today that Bob Chapek has been appointed to Masimo’s Board of Directors. Mr. Chapek was Chief Executive Officer of The Walt Disney Company, one of the world’s largest media and entertainment companies, from February 2020 to November 2022, successfully leading Disney through the global COVID-19 pandemic... Read More
Complete fourth quarter and full-year 2023 financial results will be announced on Tuesday, February 27, 2024 IRVINE, California / Jan 10, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 30, 2023 and provided estimates for its full-year 2024 guidance. Preliminary Fourth Quarter 2023 Financial Results: •... Read More
HealthStocksHub
Stork Provides Continuous Monitoring of Oxygen Saturation, Pulse Rate, and Skin Temperature, with Alarms, for Sick and Healthy Babies at Home IRVINE, Calif. / Dec 18, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of... Read More
HealthStocksHub
In the Largest Study of ORi to Date, of 554 Patients, Researchers Conclude: “ORi Can Provide Useful Information on Arterial Oxygenation Even During One-Lung Ventilation” NEUCHATEL, Switzerland / Dec 11, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal... Read More
IRVINE, Calif. / Nov 27, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:30 am ET. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq:... Read More
HealthStocksHub
IRVINE, Calif. / Nov 17, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo W1 is the first FDA-cleared watch to provide continuous real-time oxygen saturation (SpO 2 ) and pulse rate (PR)... Read More
IRVINE, Calif. / Nov 09, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Wednesday, November 15, 2023 at 3:00 pm GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a... Read More
CHICAGO & IRVINE, Calif. / Nov 08, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology ® (SET ® ) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. Portrait Mobile is built as an Internet of Medical Things (IoMT) platform, using the latest cloud native technology to... Read More
Rolf A. Classon Joins Masimo’s Board of Directors IRVINE, Calif. / Nov 07, 2023 / Business Wire / Masimo (NASDAQ: MASI) announced today that Rolf A. Classon has been appointed to Masimo’s Board of Directors. Mr. Classon is an experienced medical technology executive and board member. From October 2002 until his retirement in July 2004, he was Chairman of the Executive Committee of Bayer HealthCare AG. He served as President... Read More
Third Quarter 2023 Highlights Consolidated revenue was $478.9 million; Healthcare revenue was $307.8 million; Non-healthcare revenue was $171.1 million; GAAP net income per diluted share was $0.20; and Non-GAAP net income per diluted share was $0.63. IRVINE, Calif. / Nov 07, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter of 2023, ended September 30, 2023.... Read More
Decision Holds World’s Largest Company Accountable for Its Patent Infringement WASHINGTON / Oct 26, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with light-based pulse oximetry functionality. The USITC found that Apple (NASDAQ: AAPL) violated U.S. laws by incorporating Masimo’s... Read More
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Oct 24, 2023 / Business Wire / Masimo (NASDAQ: MASI) will release third quarter 2023 financial results for the period ended September 30, 2023, after the market closes on Tuesday, November 7, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive... Read More
HealthStocksHub
ORi to Be Launched in the U.S. at ANESTHESIOLOGY 2023 This Weekend SAN FRANCISCO / Oct 13, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen,... Read More
HealthStocksHub
LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland / Oct 09, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO ® board-in-cable... Read More
IRVINE, Calif. / Sep 07, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Friday, September 8, 2023 at 9:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is... Read More
HealthStocksHub
Leading Louisiana and Mississippi Healthcare Provider Standardizes 10 Hospitals on Masimo SET ® and Patient SafetyNet™ to Enhance Patient Safety and Improve Patient Outcomes IRVINE, Calif. / Aug 31, 2023 / Business Wire / Masimo (NASDAQ: MASI) and Franciscan Missionaries of Our Lady Health System (FMOLHS) , a 10-hospital... Read More
HealthStocksHub
IRVINE, Calif. / Aug 23, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring system. Stork Vitals+, Vitals, and Camera combinations are now available for purchase online at www.MasimoStork.com... Read More
HealthStocksHub
Researchers Found That Fluid Therapy Guided by Noninvasive, Continuous PVi Reduced Cardiopulmonary Complications and Fluid Administered NEUCHATEL, Switzerland / Aug 21, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective, randomized study published in Perioperative Medicine in which Dr.... Read More
Second Quarter 2023 Highlights Consolidated revenue was $455.3 million; Healthcare revenue was $281.1 million; Non-healthcare revenue was $174.2 million; GAAP net income per diluted share was $0.29; and Non-GAAP net income per diluted share was $0.62. IRVINE, Calif. / Aug 08, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter of 2023, ended July 1, 2023.... Read More
HealthStocksHub
Masimo PSi, a Processed EEG Parameter, “Better Captured” Changes in Brain State Compared to Other Assessment Methods IRVINE, Calif. / Aug 07, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a study published in Frontiers in Neuroscience in which Dr. Lichy Han and colleagues at Stanford University... Read More
HealthStocksHub
Management to announce and discuss complete second quarter 2023 financial results on Tuesday, August 8, 2023. IRVINE, Calif. / Jul 17, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced preliminary revenue results for the second quarter ended July 1, 2023. Preliminary Second Quarter 2023 Revenue Results... Read More
Appreciates Support From Fellow Shareholders Demonstrating Clear Mandate For Change Nominees Michelle Brennan and Quentin Koffey Are Ready to Work Constructively in the Masimo Boardroom to Benefit All Stakeholders NEW YORK / Jun 26, 2023 / Business Wire / Politan Capital Management (together with its affiliates, “Politan”), a 9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today commented on... Read More
HealthStocksHub
Top Spanish Hospital Builds on the Success of Its Postoperative Telemonitoring Program with Masimo SafetyNet ® NEUCHATEL, Switzerland / Jun 22, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1™ advanced... Read More
HealthStocksHub
Roundtable, which included a special fireside chat with Masimo Founder & Chairman Joe Kiani and President Bill Clinton, held at Clinton Foundation offices in New York City Participants included national leaders in healthcare, education, and policy NEW YORK / Jun 21, 2023 / Business Wire / Masimo (NASDAQ: MASI) and the Clinton... Read More
HealthStocksHub
Vote the WHITE Proxy Card Today Visit KeepMasimoStrong.com for More Information IRVINE, Calif. / Jun 20, 2023 / Business Wire / The Board of Directors of Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) today issued a letter to stockholders in connection with the Company’s Annual Meeting of Stockholders to be held... Read More
HealthStocksHub
IRVINE, Calif. / Jun 20, 2023 / Business Wire / Masimo (NASDAQ: MASI), a leading developer of medical technology solutions and consumer health and audio devices, is expanding its premium Denon brand to introduce its latest innovation, Masimo AAT™ (Adaptive Acoustic Technology™). Denon PerL™ and PerL Pro™ True Wireless (TWS)... Read More
HealthStocksHub
Emphasizes Track Record of Innovation Powering Growth, Stockholder Value Creation Under Joe Kiani’s Leadership Illuminates Risk Quentin Koffey Poses to Masimo’s Culture of Innovation Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card Visit... Read More
HealthStocksHub
Premier Central Valley Provider Adopts Masimo SET ® , Root ® , Rad-97 ® , and Much More Across Multiple Hospitals IRVINE, Calif. / Jun 12, 2023 / Business Wire / Masimo (NASDAQ: MASI) and Community Health System (CHS) , based in Fresno, California, today announced that CHS is adopting a variety of advanced Masimo monitoring... Read More
HealthStocksHub
NEUCHATEL, Switzerland / Jun 08, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV) , one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical... Read More
Mr. Kiani Previously Waived Other Rights in Connection with the 2023 Annual Meeting of Stockholders and the Appointment of a Lead Independent Director IRVINE, Calif. / Jun 06, 2023 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) today announced that Joe Kiani, founder, Chairman and Chief Executive Officer of Masimo, unconditionally, irrevocably and permanently waived his right to assert that a... Read More
IRVINE, Calif. / Jun 05, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a... Read More
HealthStocksHub
Transformational, Versatile, Patient-worn, Continuous Vital Signs Monitor Features Wide Range of Physiological Measurements on a Compact, Scalable Platform IRVINE, Calif. / Jun 05, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Radius VSM™ , a patient-worn, continuous multi-parameter vital signs monitor, has... Read More
Commitment to Appoint Politan Nominee as Director Reflects Board’s Openness to Qualified and Experienced Perspectives Board Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., and FOR Board Expansion on the WHITE Proxy Card IRVINE, Calif. / Jun 02, 2023 / Business Wire / On June 2, 2023, Masimo Corporation (“Masimo”) issued the following press release in... Read More
Commitment to Appoint Politan Nominee as Director Reflects Board’s Openness to Qualified and Experienced Perspectives Stockholders Do Not Need to Vote for Ms. Brennan to Add Her to Board Board Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., and FOR Board Expansion on the WHITE Proxy Card IRVINE, Calif. / Jun 02, 2023 / Business Wire / The Board of Directors... Read More
HealthStocksHub
Responds and Corrects Politan’s Inaccurate Letter Highlights Politan’s Reckless Disregard for the Truth and Fundamental Misunderstanding of Masimo’s Business Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card IRVINE, Calif. / Jun 01, 2023... Read More
Masimo’s Leadership Has Delivered Strong Returns for Investors through Sustained Profitable Above-Market Growth Masimo’s Strategy Leverages Core Competencies to Extend Growth in Core and New Markets, Create Value for All Shareholders Masimo’s Board Has Engaged Extensively with Shareholders and Acted on Their Feedback Quentin Koffey’s Unprincipled, Self-Serving Behavior and Dangerous Agenda Jeopardize Masimo’s Long-Term... Read More
HealthStocksHub
Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card Highlights Track Record of Stockholder Value Creation, Winning Strategy, Positive Governance Changes and Risks to the Company Posed by Quentin Koffey Visit KeepMasimoStrong.com for More... Read More
HealthStocksHub
Secure Masimo Health Data Tracking Now Enabled on 4 Million Devices from Denon, Marantz, and Definitive Technology IRVINE, Calif. / May 24, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the global expansion of the HEOS platform, enabling an always-on connection to the Masimo Health secure cloud for four million... Read More
IRVINE, Calif. / May 12, 2023 / Business Wire / Micah Young, Chief Financial Officer of Masimo (NASDAQ: MASI), has been awarded CFO of the Year by the Orange County Business Journal (OCBJ) . In presenting the award, Outstanding CFO of a Public Company , at last night’s ceremony in Irvine, OCBJ Publisher Richard Reisman commended Mr. Young for delivering strong shareholder returns, significantly increasing Masimo’s annual... Read More
First Quarter 2023 Highlights Consolidated revenue was $565.0 million; Healthcare revenue was $346.7 million, representing 14.0% reported growth and 15.8% constant currency growth; Non-healthcare revenue was $218.3 million; GAAP earnings per diluted share was $0.39; and Non-GAAP earnings per diluted share was $0.87. IRVINE, Calif. / May 09, 2023 / Business Wire / Masimo (Nasdaq: MASI) today announced its financial results... Read More
HealthStocksHub
NEUCHATEL, Switzerland / May 08, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch for use in its telehealth and telemedicine programs. Masimo W1, which offers accurate, continuous measurements of... Read More
HealthStocksHub
IRVINE, Calif. / May 01, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in pulse oximetry and other innovative noninvasive monitoring technologies, today announced the launch of Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data,... Read More
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Apr 25, 2023 / Business Wire / Masimo (NASDAQ: MASI) will release first quarter 2023 financial results for the period ended April 1, 2023, after the market closes on Tuesday, May 9, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer,... Read More
HealthStocksHub
IRVINE, Calif. / Apr 18, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Rad-G ® with Temperature has received FDA 510(k) clearance. Rad-G with Temperature is a rugged, versatile, handheld monitor that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ® ), and other... Read More
HealthStocksHub
Opioid Halo Is Indicated for the Detection of Opioid-Induced Respiratory Depression, with Escalating Alarms to Alert Loved Ones That Help Is Needed De Novo Authorizes Both Over-the-Counter (OTC) Use, on Adults and Children Age 15 and Up, and Prescription Use IRVINE, Calif. / Apr 03, 2023 / Business Wire / Masimo (NASDAQ: MASI)... Read More
HealthStocksHub
First of Its Kind Smartwatch Combines Masimo’s Accurate, Continuous Health Tracking Technology and Breakthrough Features in a Premium, Elegant Watch IRVINE, Calif. / Mar 28, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in pulse oximetry and innovative noninvasive monitoring technologies, unveiled the newest... Read More
H Michael Cohen Selected as Lead Independent Director Two Additional New Directors to Be Named to Board Following Consultation with Stockholders Significant Governance Changes Announced, Including Termination of Rights Agreement and Plan to Declassify Board IRVINE, Calif. / Mar 23, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced changes to its Board of Directors and governance policies, the result of... Read More
NEUCHATEL, Switzerland / Mar 15, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology and Intensive Care (ESAIC) highlight the value of noninvasive, continuous hemoglobin (Hb) monitoring in helping clinicians manage perioperative bleeding. Referencing studies using technologies such as Masimo SpHb ® , the guidelines note that “the use of... Read More
NEUCHATEL, Switzerland / Mar 09, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing evaluated the ability of noninvasive, continuous Masimo PVi ® , alongside other dynamic parameters, to predict fluid responsiveness in children 1-3 years old who were... Read More
NEUCHATEL, Switzerland / Mar 06, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi ® , as part of goal-directed fluid therapy (GDFT), to guide intraoperative fluid administration during... Read More
IRVINE, Calif. / Mar 02, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 44th Annual Raymond James Institutional Investors on Tuesday, March 7, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo... Read More
NEUCHATEL, Switzerland / Feb 21, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized controlled study published in Medicine in which Dr. Jin Hee Ahn and colleagues at the Sungkyunkwan University School of Medicine in Seoul, Korea, evaluated the ability of Masimo ORi™ to assist clinicians in guiding supplemental oxygenation during elective laparoscopic... Read More
IRVINE, Calif. / Feb 15, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Centroid ® , a wearable, wireless patient orientation and activity sensor, has received an Innovative Technology designation from Vizient, Inc. , the largest healthcare performance improvement company in the United States. Masimo exhibited Centroid in combination with the Masimo Root ® Patient Monitoring and Connectivity platform at... Read More
IRVINE, Calif. / Feb 14, 2023 / Business Wire / Masimo (NASDAQ: MASI) will release fourth quarter and FY 2022 financial results for the period ended December 31, 2022, after the market closes on Tuesday, February 28, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and... Read More
HealthStocksHub
AI-Based Video Analysis System Promotes Hand Hygiene Compliance, Integrates with Masimo Hospital Automation™ Platform IRVINE, Calif. / Jan 30, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the limited market release of Visual Clinical Activity Monitoring (VCAM™), a video analysis system that uses artificial... Read More
HealthStocksHub
Simultaneous Use of Masimo O3 ® Regional Oximetry, NomoLine ® Capnography, SedLine ® Brain Function Monitoring, and rainbow ® Pulse CO-Oximetry Helped Clinicians Determine that Maintaining Higher End-tidal Carbon Dioxide (EtCO 2 ) Improved Cerebral Oxygenation, Leading to Improved Outcomes NEUCHATEL, Switzerland / Jan 23, 2023... Read More
HealthStocksHub
Breakthrough Combination of the Masimo W1 Watch with Advanced Philips Solutions Will Become Available for Home Telehealth Applications Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with... Read More
A United States Administrative Law Judge in Washington, D.C. ruled that Apple Inc. (Nasdaq: AAPL) violated Section 337 of the Tariff Act of 1930 as amended, by importing and selling within the United States certain Apple Watches with light-based pulse oximetry functionality and components, which infringe one of Masimo’s (Nasdaq: MASI) pulse oximeter patents. Apple first released its pulse oximeter sensor with the Apple Watch... Read More
HealthStocksHub
Masimo SpHb on the Handheld Masimo Rad-67 ® Demonstrated “Acceptable Accuracy and Excellent Correlation” with Laboratory Hemoglobin Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the American Journal of Emergency Medicine in which Dr. Zohair Ahmed Ali Al Aseri and colleagues at King Saud... Read More
HealthStocksHub
Masimo (NASDAQ: MASI) today announced the findings of a before-and-after study published in PLoS ONE in which Dr. Ahmed Balshi and colleagues at King Saud Medical City in Riyadh, Saudi Arabia, evaluated the impact of implementing remote patient monitoring with Masimo Patient SafetyNet™ on the efficacy of hospital rapid... Read More
Masimo ( NASDAQ: MASI) today announced that its management will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:30 a.m. Pacific Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology... Read More
HealthStocksHub
Masimo SpHb Demonstrated “Clinically Acceptable Accuracy” of Hemoglobin Measurement, Even at Low Hemoglobin Levels Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the Egyptian Journal of Anesthesia in which Dr. Mohamed Ibrahim Beleta and colleagues at Cairo University evaluated the... Read More
Chimerix

COPYRIGHT ©2023 HEALTH STOCKS HUB